FluoroPharma Medical(OTC) FPMI

Market Cap$6.90K

Since IPO (2011)-100%

5 Year-97%

1 Year+19,900%

1 Month+0%

$0.00

+0.00%

+0.00Today

FluoroPharma Medical last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-14

FluoroPharma Medical stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-13
1 month	+0%	USD 0.00	2026-07-13
3 month	+0%	USD 0.00	2026-04-22
Year to date	+0%	USD 0.00	2025-12-22
1 year	+19,900%	USD 0.00	2025-07-29
3 year	+0%	USD 0.00	2023-07-21
5 year	-96.92%	USD 0.01	2021-08-13
Since inception	-99.99%	USD 1.35	2011-05-17

FluoroPharma Medical Financials at a Glance

Market Cap

$6.90K

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.05M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.68 (High)

Dividend

$0.00

Beta (Volatility)

3.68 (High)

Price

$0.00

Volume

30,000

Open

$0.00

Price

$0.00

Volume

30,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

Dividend

$0.00

Beta (Volatility)

3.68 (High)

Price

$0.00

Volume

30,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

FPMI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About FluoroPharma Medical

FluoroPharma Medical, Inc. is a biopharmaceutical firm focused on the discovery, development, and commercialization of advanced molecular imaging agents, primarily targeting cardiovascular applications. The company is headquartered in Montclair, New Jersey, and has a promising pipeline of innovative products aimed at improving patient outcomes in cardiovascular health.

Products and Services

BFPET: An imaging agent for stress-testing patients with coronary artery disease
CardioPET: Evaluates myocardial blood flow and metabolism in CAD patients
Collaborations with leading institutions for research and development

Growth Outlook

Successful completion of Phase I clinical trial for BFPET enhances market potential
Ongoing Phase IIa trial for CardioPET indicates progress in product development
Strategic partnerships with Massachusetts General Hospital and Sinotau USA support growth

Financial Highlights

Trailing twelve months (TTM) revenue of $0 reflects early-stage development
Recent quarterly net income of -$127,234 shows ongoing investment in R&D
Cash and cash equivalents of $24,723 provide liquidity for operational needs

FluoroPharma Medical, Inc. is positioned in the biotechnology sector, focusing on advanced imaging technologies that can significantly impact cardiovascular diagnostics. The company's commitment to innovation is evident through its clinical trials and collaborations with reputable institutions. While the financials indicate a current lack of revenue, the ongoing development of its product pipeline suggests potential for future growth. Investors may find interest in the company's strategic direction and its focus on addressing critical healthcare needs in cardiovascular medicine.

AI Generated • Jul 31, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Montclair, NJ 07042, US

FPMI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

22.73%

Return on Capital

N/A

Return on Assets

-612.34%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.90K

Shares Outstanding

34.26M

Volume

30.00K

Avg. Volume

822.222

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$2.20M

EBITDA

-$2.16M

Operating Cash Flow

-$880.12K

Capital Expenditure

-$1.29

Free Cash Flow

-$880.12K

Cash & ST Invst.

$24.72K

Total Debt

$5.82M

FluoroPharma Medical Performance Analysis

FluoroPharma Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2016-03-31	N/A
Q2	2016-06-30	N/A
Q3	2016-09-30	N/A
Q4	2016-12-31	N/A

FluoroPharma Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2016-03-31	-19.0%
Q2	2016-06-30	53.8%
Q3	2016-09-30	115.0%
Q4	2016-12-31	-212.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q4 2016YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.90K

N/A

Market Cap/Employee

$1.73K

N/A

Employees

N/A

Net Income

-$127.23K

+90.0%

EBITDA

-$508.11K

+38.4%

Quarterly Fundamentals

Name

Q4 2016YOY CHG

Total Cash

$24.72K

-91.5%

Total Debt

$5.82M

+29.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.72M

-39.4%

Return on Assets

-6.12%

N/A

Return on Invested Capital

21.64%

N/A

Free Cash Flow

-$116.24K

+88.1%

Operating Cash Flow

-$116.24K

+88.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XENOXeno Transplants Corporation

XENOXeno Transplants Corporation$0.00+0.00%

BBALNew York Health Care, Inc.

BBALNew York Health Care, Inc.$0.00+0.00%

NWCINewCardio, Inc.

NWCINewCardio, Inc.$0.00+0.00%

RBSHRebus Holdings, Inc.

RBSHRebus Holdings, Inc.$0.00+0.00%

SNNAQSienna Biopharmaceuticals, Inc.

SNNAQSienna Biopharmaceuticals, Inc.$0.00+0.00%

CMRAComera Life Sciences Holdings, Inc.

CMRAComera Life Sciences Holdings, Inc.$0.00+0.00%

SYVCSynovics Pharmaceuticals, Inc.

SYVCSynovics Pharmaceuticals, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$9.81+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$134.00-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.88-0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$41.20+0.06%

MRNAModerna

MRNAModerna$133.32-0.24%

NVDANvidia

NVDANvidia$216.85-0.00%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$17.55+0.11%

Questions About FPMI

What is the current price of FluoroPharma Medical?

FluoroPharma Medical is trading at $0.00 per share.

What is the 52-week range for FluoroPharma Medical?

Over the past 52 weeks, FluoroPharma Medical has traded between $0.00 and $0.00.

How much debt does FluoroPharma Medical have?

FluoroPharma Medical total debt is unavailable.

How much cash does FluoroPharma Medical have on hand?

FluoroPharma Medical does not have cash on hand data available.

What is FluoroPharma Medical’s dividend yield?

FluoroPharma Medical does not currently have a dividend yield.

FluoroPharma Medical(OTC) FPMI

FluoroPharma Medical Financials at a Glance

FPMI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About FluoroPharma Medical

FPMI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

FluoroPharma Medical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FPMI

What is the current price of FluoroPharma Medical?

What is the 52-week range for FluoroPharma Medical?

How much debt does FluoroPharma Medical have?

How much cash does FluoroPharma Medical have on hand?

What is FluoroPharma Medical’s dividend yield?

Premium Investing Services